Ultrafine bubble technology for enhancing oral health
Hydrosome Labs' ultrafine bubble (UFB) technology offers a novel, non-chemical approach to improve oral health by enriching the oral cavity with oxygen, promoting beneficial microbial communities and reducing gingivitis. Compatible with existing oral care products, it is ready for commercialization.
Overview
Hydrosome Labs introduces a breakthrough solution in oral health with its ultrafine bubble (UFB) technology. This innovative approach utilizes stable, air-filled nanobubbles under 200 nm suspended in water to selectively enrich the oral cavity with oxygen. Unlike traditional chemical antimicrobials, UFB technology acts as a physical modifier, fostering a healthier balance of aerobic, health-associated microbes over anaerobic pathogens. This ecological shift enhances oral microbiome balance, potentially reducing gingivitis without disrupting beneficial flora. The technology is scalable, waterborne, and seamlessly integrates with existing fluoride, surfactants, and oral care formulations such as mouthwashes and toothpastes.
Technical specifications
- Nanobubble generation: Produces stable, air-filled bubbles under 200 nm.
- Functionality: Modifies the microenvironment to favor aerobic microbes and suppress anaerobic pathogens.
- Compatibility: Works with existing oral care products, including fluoride and surfactants.
- Enhanced delivery: Improves mass transfer for effective delivery of co-formulated prebiotics or postbiotics.
- Scalability: Suitable for large-scale manufacturing and commercial integration.
Technology readiness level
Hydrosome Labs' UFB technology is at Technology Readiness Level 9, indicating it is fully developed and validated for commercial application. Extensive preclinical studies have demonstrated its efficacy in modulating microbiome composition and reducing inflammatory markers associated with gingivitis. The technology is poised for market entry with ongoing formulation development and efficacy validation efforts.
About Hydrosome Labs
Hydrosome Labs is a biotechnology company that specializes in ultrafine bubble technology. The company has developed a patented process called Hydrosome H2O, which utilizes hydrodynamic cavitation to create stable, microscopic structures known as Hydrosomes. Unlike conventional nanobubbles, these ultrafine bubbles are designed to remain active in solution for more than a year. By leveraging their unique size, concentration, and electrostatic properties, Hydrosomes operate on an attract-and-deliver mechanism, improving the transport and bioavailability of nutrients, vitamins, and gases directly to cells and tissues. This chemical-free innovation allows for the modification of water to enhance the performance and efficacy of water-based solutions across various industries.
The technology provides significant value to partners in sectors such as personal care, functional beverages, precision fermentation, and controlled environment agriculture. By enabling more efficient nutrient uptake and hydration, Hydrosome H2O helps manufacturers improve product performance, increase yields, and reduce reliance on chemicals, thereby minimizing environmental impact and streamlining supply chains. The company, which is based in Westmont, Illinois, operates on a business-to-business model, licensing its technology to firms seeking to enhance their product offerings. Hydrosome Labs supports its scientific approach with extensive research and collaborations with clinical research laboratories and academic investigators.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.